Literature DB >> 34889379

When to worry about inherited bone marrow failure and myeloid malignancy predisposition syndromes in the setting of a hypocellular marrow.

Anupama Narla1.   

Abstract

With our increasing understanding of inherited marrow failure and myeloid malignancy predisposition syndromes, it has become clear that there is a wide phenotypic spectrum and that these diseases must be considered in the differential diagnosis of both children and adults with unexplained defects in hematopoiesis. Moreover, these conditions are not as rare as previously believed and may present as aplastic anemia, myelodysplastic syndrome, or malignancy over a range of ages. Establishing the correct diagnosis is essential because it has implications for treatment, medical management, cancer screening, and family planning. Our goal is to highlight insights into the pathophysiology of these diseases, review cryptic presentations of these syndromes, and provide useful references for the practicing hematologist.
Copyright © 2021 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2021        PMID: 34889379      PMCID: PMC8791095          DOI: 10.1182/hematology.2021000246

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  13 in total

1.  THE SYNDROME OF PANCREATIC INSUFFICIENCY AND BONE MARROW DYSFUNCTION.

Authors:  H SHWACHMAN; L K DIAMOND; F A OSKI; K T KHAW
Journal:  J Pediatr       Date:  1964-11       Impact factor: 4.406

Review 2.  Ribosomopathies: human disorders of ribosome dysfunction.

Authors:  Anupama Narla; Benjamin L Ebert
Journal:  Blood       Date:  2010-03-01       Impact factor: 22.113

3.  Cancer spectrum and outcomes in the Mendelian short telomere syndromes.

Authors:  Kristen E Schratz; Lisa Haley; Sonye K Danoff; Amanda L Blackford; Amy E DeZern; Christopher D Gocke; Amy S Duffield; Mary Armanios
Journal:  Blood       Date:  2020-05-28       Impact factor: 22.113

4.  Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome.

Authors:  Amy P Hsu; Elizabeth P Sampaio; Javed Khan; Katherine R Calvo; Jacob E Lemieux; Smita Y Patel; David M Frucht; Donald C Vinh; Roger D Auth; Alexandra F Freeman; Kenneth N Olivier; Gulbu Uzel; Christa S Zerbe; Christine Spalding; Stefania Pittaluga; Mark Raffeld; Douglas B Kuhns; Li Ding; Michelle L Paulson; Beatriz E Marciano; Juan C Gea-Banacloche; Jordan S Orange; Jennifer Cuellar-Rodriguez; Dennis D Hickstein; Steven M Holland
Journal:  Blood       Date:  2011-06-13       Impact factor: 22.113

Review 5.  Fanconi anemia.

Authors:  Grover C Bagby; Blanche P Alter
Journal:  Semin Hematol       Date:  2006-07       Impact factor: 3.851

6.  Dyskeratosis congenita.

Authors:  Sharon A Savage; Blanche P Alter
Journal:  Hematol Oncol Clin North Am       Date:  2009-04       Impact factor: 3.722

Review 7.  Ribosome biogenesis in cancer: new players and therapeutic avenues.

Authors:  Joffrey Pelletier; George Thomas; Siniša Volarević
Journal:  Nat Rev Cancer       Date:  2017-12-01       Impact factor: 60.716

8.  Diagnostic utility of telomere length testing in a hospital-based setting.

Authors:  Jonathan K Alder; Vidya Sagar Hanumanthu; Margaret A Strong; Amy E DeZern; Susan E Stanley; Clifford M Takemoto; Ludmila Danilova; Carolyn D Applegate; Stephen G Bolton; David W Mohr; Robert A Brodsky; James F Casella; Carol W Greider; J Brooks Jackson; Mary Armanios
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-20       Impact factor: 11.205

Review 9.  VEXAS syndrome.

Authors:  Peter C Grayson; Bhavisha A Patel; Neal S Young
Journal:  Blood       Date:  2021-07-01       Impact factor: 25.476

10.  Identification of RPS14 as a 5q- syndrome gene by RNA interference screen.

Authors:  Benjamin L Ebert; Jennifer Pretz; Jocelyn Bosco; Cindy Y Chang; Pablo Tamayo; Naomi Galili; Azra Raza; David E Root; Eyal Attar; Steven R Ellis; Todd R Golub
Journal:  Nature       Date:  2008-01-17       Impact factor: 49.962

View more
  2 in total

Review 1.  Overview of inherited bone marrow failure syndromes.

Authors:  Meerim Park
Journal:  Blood Res       Date:  2022-04-30

Review 2.  Aplastic Anemia as a Roadmap for Bone Marrow Failure: An Overview and a Clinical Workflow.

Authors:  Antonio G Solimando; Carmen Palumbo; Mary Victoria Pragnell; Max Bittrich; Antonella Argentiero; Markus Krebs
Journal:  Int J Mol Sci       Date:  2022-10-04       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.